Details of the Drug

General Information of Drug (ID: DM6URNJ)

Drug Name
JNJ-67856633
Indication
Disease Entry ICD 11 Status REF
Chronic lymphocytic leukaemia 2A82.0 Phase 1 [1]
Non-hodgkin lymphoma 2B33.5 Phase 1 [1]
Cross-matching ID
PubChem CID
134609793
TTD ID
D3GIQ9
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
MALT lymphoma-associated translocation (MALT1) TTCI81G MALT1_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03900598) A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). U.S. National Institutes of Health.
2 National Cancer Institute Drug Dictionary (drug name JNJ67856633).